Acadia Pharmaceuticals Inc. (ACAD)

[gi197845]

ACADIA Investigated by Block & Leviton LLP For Violations of Federal Securities Laws;

(Leviton LLP should be investigating the fake hit piece by CNN and suing CNN instead...)

Jul 18, 2018 11:55:00 (ET)

BOSTON, July 18, 2018 /PRNewswire/ -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether ACADIA Pharmaceuticals, Inc. ("ACADIA" or the "Company") (NASDAQ: ACAD) and certain of its officers and directors violated federal securities laws.

On April 9, 2018, CNN reported that ACADIA's Nuplazid treatment may have played a role in the death of ill and elderly patients. On this news, shares in the Company plunged 23%. Subsequently, on July 9, 2018, the Southern Investigative Reporting Foundation released a report alleging that the Company's approach to government approval is best described as "loophole-centric." Following this report, the Company's shares dropped more than 6%.

If you purchased or otherwise acquired ACADIA securities and have questions about your legal rights, or possess information relevant to this investigation, you are encouraged to contact attorney John DeFelice at [phone], by email at [e-mail] or by visiting http://shareholder.law/acadia.

Block & Leviton LLP was recently ranked 4th among securities litigation firms by ISS for recoveries in 2017. The firm represents many of the nations' largest institutional investors and numerous individual investors in securities litigation throughout the country. Indeed, its lawyers have recovered billions of dollars for its clients.

This notice may constitute attorney advertising.

CONTACT:

BLOCK & LEVITON LLP

John DeFelice

[phone] phone

155 Federal Street, Suite 400

Boston, MA 02110

[e-mail]

View original content:http://www.prnewswire.com/news-releases/acadia-pharmaceuticals-inc-acad-investigated-by-block--leviton-llp-for-violations-of-federal-securities-laws-300683034.html

SOURCE Block & Leviton LLP

/Web site: http://www.blockesq.com

(END) Dow Jones Newswires

July 18, 2018 11:55 ET (15:55 GMT)